Sang-Geon Cho1, Ki Seong Park1, Jahae Kim1, Sae-Ryung Kang2, Seong Young Kwon2, Hyun Ju Seon3, Zeenat Jabin2, Young Jae Kim2, Geum-Cheol Jeong2, Minchul Song2, Ho-Chun Song1, Jung-Joon Min2, Hee-Seung Bom4. 1. Department of Nuclear Medicine, Chonnam National University Hospital, 42, Jebong-ro, Dong-gu, Gwang-ju, 61469, Republic of Korea. 2. Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 322, Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do, 58128, Republic of Korea. 3. Department of Radiology, Chonnam National University Hwasun Hospital, 322, Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do, 58128, Republic of Korea. 4. Department of Nuclear Medicine, Chonnam National University Hwasun Hospital, 322, Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeollanam-do, 58128, Republic of Korea. hsbom@jnu.ac.kr.
Abstract
PURPOSE: The purpose of this study is to evaluate whether fluorodeoxyglucose (FDG) uptake of the large arteries can predict coronary artery calcium (CAC) progression in asymptomatic individuals. METHODS: Ninety-six asymptomatic individuals who underwent FDG positron emission tomography (PET) and CAC scoring on the same day for health screening and follow-up CAC scoring ≥1 year after baseline studies (mean 4.3 years) were included. Vascular FDG uptake was measured and corrected for blood pool activity to obtain peak and average target-to-blood pool ratios (TBRpeak and TBRavg, respectively) for the carotid arteries, and ascending and abdominal aorta. CAC scores at baseline and follow-up of each individual were measured and absolute CAC change (ΔCAC), annual CAC change (ΔCAC/year), and annual CAC change rate (ΔCAC%/year) were calculated. CAC progression was defined as ΔCAC >0 for individuals with negative baseline CAC; ΔCAC/year ≥10 for those with baseline CAC of 0<x<100; ΔCAC%/year ≥10 % for those with baseline CAC ≥100. Vascular FDG uptake and other clinical risk factors were compared between CAC-progressors and non-CAC-progressors. Multivariate analysis was performed to evaluate whether vascular FDG uptake can independently predict CAC progression. RESULTS: Thirty-one subjects showed CAC progression. CAC-progressors showed significantly higher TBRpeak and TBRavg as compared to non-CAC-progressors for all three arteries. TBRpeak of the abdominal aorta was significantly associated with CAC progression in multivariate analysis, with age and baseline CAC. A higher TBRpeak of the abdominal aorta (≥2.11) was associated with CAC progression among subjects with negative baseline CAC only. In subjects with positive baseline CAC, only the amount of baseline CAC was significantly associated with CAC progression. However, the positive predictive value of the TBRpeak of the abdominal aorta was <40 % when age was <58 or baseline CAC was negative. CONCLUSIONS: Higher FDG uptake of the large arteries is associated with an increased risk of CAC progression in asymptomatic subjects with negative baseline CAC. But its clinical application needs further validation.
PURPOSE: The purpose of this study is to evaluate whether fluorodeoxyglucose (FDG) uptake of the large arteries can predict coronary artery calcium (CAC) progression in asymptomatic individuals. METHODS: Ninety-six asymptomatic individuals who underwent FDG positron emission tomography (PET) and CAC scoring on the same day for health screening and follow-up CAC scoring ≥1 year after baseline studies (mean 4.3 years) were included. Vascular FDG uptake was measured and corrected for blood pool activity to obtain peak and average target-to-blood pool ratios (TBRpeak and TBRavg, respectively) for the carotid arteries, and ascending and abdominal aorta. CAC scores at baseline and follow-up of each individual were measured and absolute CAC change (ΔCAC), annual CAC change (ΔCAC/year), and annual CAC change rate (ΔCAC%/year) were calculated. CAC progression was defined as ΔCAC >0 for individuals with negative baseline CAC; ΔCAC/year ≥10 for those with baseline CAC of 0<x<100; ΔCAC%/year ≥10 % for those with baseline CAC ≥100. Vascular FDG uptake and other clinical risk factors were compared between CAC-progressors and non-CAC-progressors. Multivariate analysis was performed to evaluate whether vascular FDG uptake can independently predict CAC progression. RESULTS: Thirty-one subjects showed CAC progression. CAC-progressors showed significantly higher TBRpeak and TBRavg as compared to non-CAC-progressors for all three arteries. TBRpeak of the abdominal aorta was significantly associated with CAC progression in multivariate analysis, with age and baseline CAC. A higher TBRpeak of the abdominal aorta (≥2.11) was associated with CAC progression among subjects with negative baseline CAC only. In subjects with positive baseline CAC, only the amount of baseline CAC was significantly associated with CAC progression. However, the positive predictive value of the TBRpeak of the abdominal aorta was <40 % when age was <58 or baseline CAC was negative. CONCLUSIONS: Higher FDG uptake of the large arteries is associated with an increased risk of CAC progression in asymptomatic subjects with negative baseline CAC. But its clinical application needs further validation.
Authors: Mathias Goyen; Christoph U Herborn; Knut Kröger; Thomas C Lauenstein; Jörg F Debatin; Stefan G Ruehm Journal: Radiology Date: 2003-02-19 Impact factor: 11.105
Authors: K von Kemp; P van den Brande; T Peterson; S Waegeneers; T Scheerlinck; W Danau; F van Tussenbroek; E Debing; I Staelens Journal: Int Angiol Date: 1997-06 Impact factor: 2.789
Authors: John W McEvoy; Michael J Blaha; Andrew P Defilippis; Matthew J Budoff; Khurram Nasir; Roger S Blumenthal; Steven R Jones Journal: J Am Coll Cardiol Date: 2010-11-09 Impact factor: 24.094
Authors: Irfan Zeb; Dong Li; Khurram Nasir; Jennifer Malpeso; Aisha Batool; Ferdinand Flores; Christopher Dailing; Ronald P Karlsberg; Matthew Budoff Journal: Atherosclerosis Date: 2013-08-29 Impact factor: 5.162
Authors: M C Marzola; B Saboury; S Chondrogiannis; L Rampin; G Grassetto; A Ferretti; A Alavi; D Rubello Journal: Rev Esp Med Nucl Imagen Mol Date: 2013-05-30 Impact factor: 1.359
Authors: James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Mark Woodward; Valentin Fuster; Michael E Farkouh; Zahi A Fayad Journal: Circ Cardiovasc Imaging Date: 2009-01-26 Impact factor: 7.792
Authors: Amy C Alman; Gregory L Kinney; Russell P Tracy; David M Maahs; John E Hokanson; Marian J Rewers; Janet K Snell-Bergeon Journal: Diabetes Care Date: 2013-01-22 Impact factor: 19.112
Authors: Laura Geraldino-Pardilla; Afshin Zartoshti; Ayse Bag Ozbek; Jon T Giles; Richard Weinberg; Mona Kinkhabwala; Sabahat Bokhari; Joan M Bathon Journal: Arthritis Rheumatol Date: 2017-12-01 Impact factor: 10.995
Authors: Michael Mayer; Austin J Borja; Emily C Hancin; Thomas Auslander; Mona-Elisabeth Revheim; Mateen C Moghbel; Thomas J Werner; Abass Alavi; Chamith S Rajapakse Journal: Front Physiol Date: 2020-10-22 Impact factor: 4.566